Cargando…
Macular hole and serous pigment epithelial detachment in bilateral acquired vitelliform lesions
PURPOSE: Acquired vitelliform lesions (AVLs) are associated with age-related macular degeneration and other variable macular disorders. AVLs often lead to outer retinal atrophy, sometimes accompanying a macular hole and choroidal neovascularization. The purpose of this study was to report a rare cas...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049591/ https://www.ncbi.nlm.nih.gov/pubmed/32140615 http://dx.doi.org/10.1016/j.ajoc.2020.100628 |
_version_ | 1783502470019809280 |
---|---|
author | Yata, Nana Yasukawa, Tsutomu Kawamura, Mihoko Hirano, Yoshio Ogura, Yuichiro |
author_facet | Yata, Nana Yasukawa, Tsutomu Kawamura, Mihoko Hirano, Yoshio Ogura, Yuichiro |
author_sort | Yata, Nana |
collection | PubMed |
description | PURPOSE: Acquired vitelliform lesions (AVLs) are associated with age-related macular degeneration and other variable macular disorders. AVLs often lead to outer retinal atrophy, sometimes accompanying a macular hole and choroidal neovascularization. The purpose of this study was to report a rare case with bilateral AVLs, in which one eye had accompanied a macular hole and the second eye a serous pigment epithelial detachment (sPED). OBSERVATIONS: A 66-year-old woman complained of bilateral metamorphopsia. AVLs were observed in the right eye and a flat sPED in the left eye. The best-corrected visual acuity (BCVA) was 20/17 in both eyes. Fluorescein angiography revealed local leakage in the right eye and pattern dystrophy-like hypofluorescence in both eyes. The sPED progressed with AVLs in the left eye and was treated with a combination therapy of intravitreal aflibercept, a sub-Tenon's injection of triamcinolone acetonide, and photodynamic therapy (IVA/STTA/PDT), which successfully flattened the sPED and sustained good vision for 4 years. The right eye was treated with intravitreal ranibizumab and tissue plasminogen activator, which enhanced absorption of the vitelliform material. However, 14 months later, a macular hole with typical metamorphopsia formed above a subretinal fibrotic scar at the vitelliruptive stage. Although pars plana vitrectomy closed the macular hole, enlargement of the outer retinal atrophy worsened the BCVA to 20/100. CONCLUSIONS AND IMPORTANCE: We successfully treated one eye with a sPED with AVLs using the combination therapy of IVA/STTA/PDT, while the second eye with a macular hole secondary to AVLs ultimately developed outer retinal atrophy with visual loss. |
format | Online Article Text |
id | pubmed-7049591 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-70495912020-03-05 Macular hole and serous pigment epithelial detachment in bilateral acquired vitelliform lesions Yata, Nana Yasukawa, Tsutomu Kawamura, Mihoko Hirano, Yoshio Ogura, Yuichiro Am J Ophthalmol Case Rep Case Report PURPOSE: Acquired vitelliform lesions (AVLs) are associated with age-related macular degeneration and other variable macular disorders. AVLs often lead to outer retinal atrophy, sometimes accompanying a macular hole and choroidal neovascularization. The purpose of this study was to report a rare case with bilateral AVLs, in which one eye had accompanied a macular hole and the second eye a serous pigment epithelial detachment (sPED). OBSERVATIONS: A 66-year-old woman complained of bilateral metamorphopsia. AVLs were observed in the right eye and a flat sPED in the left eye. The best-corrected visual acuity (BCVA) was 20/17 in both eyes. Fluorescein angiography revealed local leakage in the right eye and pattern dystrophy-like hypofluorescence in both eyes. The sPED progressed with AVLs in the left eye and was treated with a combination therapy of intravitreal aflibercept, a sub-Tenon's injection of triamcinolone acetonide, and photodynamic therapy (IVA/STTA/PDT), which successfully flattened the sPED and sustained good vision for 4 years. The right eye was treated with intravitreal ranibizumab and tissue plasminogen activator, which enhanced absorption of the vitelliform material. However, 14 months later, a macular hole with typical metamorphopsia formed above a subretinal fibrotic scar at the vitelliruptive stage. Although pars plana vitrectomy closed the macular hole, enlargement of the outer retinal atrophy worsened the BCVA to 20/100. CONCLUSIONS AND IMPORTANCE: We successfully treated one eye with a sPED with AVLs using the combination therapy of IVA/STTA/PDT, while the second eye with a macular hole secondary to AVLs ultimately developed outer retinal atrophy with visual loss. Elsevier 2020-02-24 /pmc/articles/PMC7049591/ /pubmed/32140615 http://dx.doi.org/10.1016/j.ajoc.2020.100628 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Yata, Nana Yasukawa, Tsutomu Kawamura, Mihoko Hirano, Yoshio Ogura, Yuichiro Macular hole and serous pigment epithelial detachment in bilateral acquired vitelliform lesions |
title | Macular hole and serous pigment epithelial detachment in bilateral acquired vitelliform lesions |
title_full | Macular hole and serous pigment epithelial detachment in bilateral acquired vitelliform lesions |
title_fullStr | Macular hole and serous pigment epithelial detachment in bilateral acquired vitelliform lesions |
title_full_unstemmed | Macular hole and serous pigment epithelial detachment in bilateral acquired vitelliform lesions |
title_short | Macular hole and serous pigment epithelial detachment in bilateral acquired vitelliform lesions |
title_sort | macular hole and serous pigment epithelial detachment in bilateral acquired vitelliform lesions |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049591/ https://www.ncbi.nlm.nih.gov/pubmed/32140615 http://dx.doi.org/10.1016/j.ajoc.2020.100628 |
work_keys_str_mv | AT yatanana macularholeandserouspigmentepithelialdetachmentinbilateralacquiredvitelliformlesions AT yasukawatsutomu macularholeandserouspigmentepithelialdetachmentinbilateralacquiredvitelliformlesions AT kawamuramihoko macularholeandserouspigmentepithelialdetachmentinbilateralacquiredvitelliformlesions AT hiranoyoshio macularholeandserouspigmentepithelialdetachmentinbilateralacquiredvitelliformlesions AT ogurayuichiro macularholeandserouspigmentepithelialdetachmentinbilateralacquiredvitelliformlesions |